{
    "matched_specifications": [
        [
            "study",
            "maps phase ii"
        ],
        [
            "treatment",
            "chemotherapy plus sorafenib"
        ],
        [
            "ldh serum levels",
            "> unr"
        ],
        [
            "patients number",
            "6"
        ],
        [
            "patients percentage",
            "8%"
        ]
    ],
    "unmatched_specifications": [
        [
            "population",
            "study population"
        ],
        [
            "stratification",
            "ldh serum levels and treatment"
        ]
    ],
    "unmatched_extracted_keys": [
        "stratification"
    ],
    "unmatched_extracted_values": [
        "ldh serum levels and treatment",
        "study population"
    ],
    "unmatched_ground_truth_keys": [
        "os p-value",
        "unit",
        "os (months)",
        "analysis",
        "pfs (months)",
        "pfs p-value"
    ],
    "unmatched_ground_truth_values": [
        "0.0012",
        "2.8",
        "pfs and os",
        "5.9",
        "0.05",
        "sorafenib group",
        "months"
    ],
    "mapped_keys": {
        "treatment": "treatment",
        "patients percentage": "patients percentage",
        "patients number": "patients number",
        "study": "study",
        "population": "population subgroup",
        "ldh serum levels": "ldh level"
    },
    "mapped_values": {
        "maps phase ii": "maps phase ii",
        "chemotherapy plus sorafenib": "chemotherapy plus sorafenib",
        "8%": "8%",
        "6": "6",
        "> unr": "ldh > unr"
    },
    "precision": 0.7142857142857143,
    "recall": 0.4166666666666667
}